Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 123,794 | 187,675 | 154,901 | 128,994 | 322,536 |
| Marketable Securities | N/A | 284,255 | 236,949 | 213,591 | N/A |
| Receivables | 248,855 | 234,597 | 204,494 | 188,318 | 152,380 |
| Inventories | 173,303 | 164,318 | 158,034 | 188,833 | 160,342 |
| Income taxes - deferred | N/A | N/A | N/A | 39,829 | 37,689 |
| Other current assets | 108,220 | 101,140 | 91,206 | 62,069 | 86,451 |
| TOTAL | $654,172 | $971,985 | $845,584 | $821,634 | $759,398 |
| Non-Current Assets | |||||
| PPE Net | 437,270 | 379,096 | 357,422 | 333,026 | 303,587 |
| Intangibles | 256,314 | 243,719 | 46,155 | 234,843 | 249,572 |
| Other Non-Current Assets | 189,593 | 118,616 | 281,543 | 85,490 | 71,654 |
| TOTAL | $883,177 | $741,431 | $685,120 | $653,359 | $624,813 |
| Total Assets | $1,537,349 | $1,713,416 | $1,530,704 | $1,474,993 | $1,384,211 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 69,534 | 66,968 | 60,057 | 52,648 | 44,743 |
| Accrued Expenses | 260,683 | 253,418 | 236,131 | 205,530 | 195,351 |
| TOTAL | $770,444 | $1,004,567 | $934,568 | $856,761 | $820,906 |
| Non-Current Liabilities | |||||
| Long Term Debt | 601,348 | 606,075 | 593,110 | 597,085 | 350,000 |
| Deferred Revenues | 41,290 | 29,181 | 27,380 | 25,583 | 31,812 |
| Other Non-Current Liabilities | 84,810 | 95,593 | 38,928 | 28,641 | 32,318 |
| TOTAL | $776,138 | $762,691 | $704,349 | $702,227 | $445,716 |
| Total Liabilities | $1,546,582 | $1,767,258 | $1,638,917 | $1,558,988 | $1,266,622 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,007 | 87,123 | 88,005 | 89,638 | 94,251 |
| Common Shares | 10,509 | 10,428 | 10,334 | 10,258 | 10,195 |
| Retained earnings | 1,167,928 | 803,545 | 540,401 | 318,356 | 1,675,299 |
| Other shareholders' equity | -36,886 | -29,746 | -37,843 | -37,143 | -3,198 |
| TOTAL | $-9,233 | $-53,842 | $-108,213 | $-83,995 | $117,589 |
| Total Liabilities And Equity | $1,537,349 | $1,713,416 | $1,530,704 | $1,474,993 | $1,384,211 |